Artificial Intelligence and Eye Disease

Dear Colleagues,

This Special Issue entitled Artificial Intelligence (AI) and Eye Disease explores how AI technologies are revolutionizing the diagnosis, treatment, and management of ocular conditions. This collection highlights key advancements, clinical applications, and challenges in integrating AI into ophthalmology.

Key Themes and Highlights:

1. AI in Early Diagnosis:

• AI algorithms demonstrate high sensitivity and specificity in detecting diseases like diabetic retinopathy, age-related macular degeneration, cataract, and glaucoma.

Advances in Imaging:

• The AI-driven analysis or image processing of imaging modalities such as OCT, OCT-A, and fundus photography enables precise diagnostics and personalized treatment planning (i.e., IOL calculation).

Treatment Monitoring:

• AI tools help track disease progression and therapy responses, assisting clinicians in optimizing treatment.

Future Directions:

• Topics include AI’s integration with telemedicine, surgical robotics, and augmented reality, signaling its role in the future of ophthalmology.

Relevance and Impact:

This Special Issue showcases AI’s transformative potential to enhance clinical outcomes in ophthalmology. However, addressing challenges through collaboration among clinicians and data scientists remains critical. The insights offered highlight AI’s pivotal role in shaping the future of eye disease management.

Prof. Dr. Andrzej Grzybowski
Dr. Louis Arnould
Prof. Dr. Haoyu Chen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.